Government Accountability Office (GAO) Reports
The Government Accountability Office (GAO) is an independent, nonpartisan Congressional agency that provides reports at the request of congressional committees/subcommittees or as mandated by public laws to ensure accountability in government activities.
Medicare Part D: Instances of Questionable Access to Rx Drugs | September 2011
A report from the GAO that examines indications of doctor shopping in the Medicare Part D program for 14 categories of frequently abused prescription drugs.
View Report
Nursing Homes: Private Investment Homes Sometimes Differed from Others in Deficiencies, Staffing, and Financial Performance | July 2011
A report from the GAO that examines the impact of Private Investor ownership on the quality of care provided and on nursing homes’ financial performance.
View Report
Medicare Part D: Changes in Utilization Similar for Randomly Reassigned and Other Low-Income Subsidy Beneficiaries | June 2011
A report from the GAO that examines the features of benchmark PDPs and explore how the random reassignment process may affect beneficiaries’ drug utilization.
View Report
Medicare Part D Spending, Beneficiary Out-of-Pocket Costs, and Efforts to Obtain Price Concessions for Certain High-Cost Drugs | March 2011
A report from the GAO that examines beneficiary cost sharing and access to certain high-cost pharmaceuticals.
View Report
Trends in Usual and Customary Prices for Commonly Used Drugs | February 2011
A report from the GAO that reviews recent trends in drug prices for brand-name and generic pharmaceuticals.
View Report
Private Sector Initiatives to Bundle Hospital and Physician Payments for an Episode of Care | January 2011
A report from the GAO that examines types of services and the administration of private payer bundled payments for an episode of care and the views of national experts on increased use of bundled payments in Medicare.
View Report
Medicare Part D Spending, Beneficiary Cost Sharing, and Cost-Containment Efforts for High-Cost Drugs Eligible for a Specialty Tier | January 2010
A report from the GAO that reviews the cost sharing and government spending associated with Part D coverage of specialty tier high-cost drugs.
View Report
Medicare Advantage Characteristics, Financial Risks, and Disenrollment Rates of Beneficiaries in Private Fee-for-Service Plans | December 2008
A report from the GAO that reviews characteristics of beneficiaries enrolled in Private Medicare Advantage Fee-For-Service Plans.
View Report
Medicare Part D Prescription Drug Coverage: Federal Oversight of Reported Price Concessions Data | September 2008
A report from the GAO that provides an overview on the price concessions data collected by CMS.
View Report
Medicare Part D: Complaint Rates Are Declining, but Operational and Oversight Challenges Remain | June 2008
A report from the GAO that evaluates complaints data from 2006-2007 that indicates ongoing challenges for some Medicare Part D beneficiaries.
View Report
Medicare Part D: Plan Sponsors’ Processing and CMS Monitoring of Drug Coverage Requests Could Be Improved | January 2008
A report from the GAO that evaluates the process of coverage requests for drugs with restrictions.
View Report
Medicare Part D: Challenges in Enrolling New Dual-Eligible Beneficiaries | May 2007
A report from the GAO that reviews ongoing challenges for dual-eligible beneficiaries, pharmacies, and the Medicare program in implementing the Part D program and steps taken by CMS to address them.
View Report
View Summary
Back to the top